Meta Biomed Co. Ltd Cash Flow Quality Index
Meta Biomed Co. Ltd cash flow quality index. Meta Biomed Co. Ltd (059210) has a Cash Flow Quality Index of 0.24x as of September 2025. Operating cash flow of ₩1.05 Billion is below net income of ₩4.46 Billion, suggesting accrual-heavy earnings not yet converted to cash. See Meta Biomed Co. Ltd leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Meta Biomed Co. Ltd (2011–2024)
Cash flow quality index of Meta Biomed Co. Ltd from 2011 to 2024. Historical Cash Flow Quality Index for Meta Biomed Co. Ltd across 10 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore cash flow to debt ratio of Meta Biomed Co. Ltd to assess how comfortably operating cash covers total debt obligations.
Meta Biomed Co. Ltd Cash Flow Quality Index by Year (2011–2024)
Meta Biomed Co. Ltd cash flow quality index by year from 2011 to 2024. Year-by-year earnings quality comparison for Meta Biomed Co. Ltd. For the full cash flow conversion analysis, see cash flow conversion of Meta Biomed Co. Ltd.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.01x | ₩22.63 Billion | ₩22.32 Billion | ▼ -2.6% |
| 2023 | 1.04x | ₩10.22 Billion | ₩9.82 Billion | ▼ -70.1% |
| 2022 | 3.49x | ₩9.16 Billion | ₩2.63 Billion | ▲ +198.0% |
| 2021 | 1.17x | ₩11.14 Billion | ₩9.52 Billion | ▲ +36.6% |
| 2019 | 0.86x | ₩2.86 Billion | ₩3.35 Billion | ▼ -87.3% |
| 2016 | 6.72x | ₩5.03 Billion | ₩748.74 Million | ▲ +32.1% |
| 2015 | 5.09x | ₩4.93 Billion | ₩969.74 Million | ▲ +197.5% |
| 2013 | 1.71x | ₩3.71 Billion | ₩2.17 Billion | ▲ +4.0% |
| 2012 | 1.64x | ₩3.83 Billion | ₩2.33 Billion | ▼ -52.8% |
| 2011 | 3.48x | ₩4.10 Billion | ₩1.18 Billion | — |